Model Number 3300TFX |
Device Problems
Perivalvular Leak (1457); Insufficient Information (3190)
|
Patient Problems
Dyspnea (1816); Insufficient Information (4580)
|
Event Date 11/03/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Event Description
|
It was learned through implant patient registry that a patient with a 27mm 3300tfx aortic valve was explanted after an implant duration of 4 years, 8 months due to unknown reasons.The explanted valve was replaced with a 27mm 11500a valve.The patient was in recovery post procedure.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional customer complaint.The information reported may or may not be related to the edwards device.
|
|
Manufacturer Narrative
|
Updated sections: b5, b7, g3, g6, h6 health effect - clinical code, device code(s), and type of investigation.
|
|
Event Description
|
It was learned through implant patient registry and investigation that a patient with a 27mm 3300tfx aortic valve was explanted after an implant duration of 4 years, 8 months due to dehiscence with perivalvular leak and possibly of endocarditis remains high.The explanted valve was replaced with a 27mm 11500a valve.Per medical records, the patient presents with shortness of breath and underwent a redo avr and tvr - tricuspid insufficiency with a mc3 ring.Intraoperatively the aortic valve was easily excised from the annulus, there was evidence of dehiscence with no evidence of pus, cultures were sent.A 27mm 11500a valve was implanted.Upon weaning from bypass, tee demonstrated well-seated bioprosthesis without any evidence of paravalvular leak, the tricuspid valve been reduced to almost i+ tricuspid valvular insufficiency.The patient tolerated the procedure well and was transferred to the intensive care unit in stable and satisfactory condition and discharged on pod #6.
|
|
Manufacturer Narrative
|
Updated sections: d4 expiration date, and udi number, g3, g6, h4, h6 component code, type of investigation, investigation findings, and investigation conclusions.The device history record was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.Device dehiscence may occur early or late.When it occurs in the intraoperative period, it is typically a result of inadequate device implantation in combination with friable myocardial tissue.Valve dehiscence is not a malfunction related to a manufacturing deficiency of the device.A definitive root cause cannot be conclusively determined; however, patient and/or procedural factors likely caused or contributed to the event.
|
|
Search Alerts/Recalls
|
|